GAL3ST2
Galactose-3-O-sulfotransferase 2
Also known as: G3ST2_HUMAN, GP3ST
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H3Q3
- Gene
- GAL3ST2
- Ensembl
- ENSG00000154252
- Chromosome
- 2
- Canonical length
- 398 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the galactose-3-O-sulfotransferase protein family. The product of this gene catalyzes sulfonation by transferring a sulfate group to the hydroxyl at C-3 of nonreducing beta-galactosyl residues, and it can act on both type 1 and type 2 (Galbeta 1-3/1-4GlcNAc-R) oligosaccharides with similar efficiencies, and on core 1 glycans. This enzyme has been implicated in tumor metastasis processes. This gene is different from the GAL3ST3 gene located on chromosome 11, which has also been referred to as GAL3ST2 and encodes a related enzyme with distinct tissue distribution and substrate specificities, compared to galactose-3-O-sulfotransferase 2. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
398 residues, UniProt reviewed canonical sequence.
>Q9H3Q3|GAL3ST2
1 MMSMLGGLQR YFRVILLLLL ALTLLLLAGF LHSDLELDTP LFGGQAEGPP VTNIMFLKTH
61 KTASSTVLNI LYRFAETHNL SVALPAGSRV HLGYPWLFLA RYVEGVGSQQ RFNIMCNHLR
121 FNLPQVQKVM PNDTFYFSIL RNPVFQLESS FIYYKTYAPA FRGAPSLDAF LASPRTFYND
181 SRHLRNVYAK NNMWFDFGFD PNAQCEEGYV RARIAEVERR FRLVLIAEHL DESLVLLRRR
241 LRWALDDVVA FRLNSRSARS VARLSPETRE RARSWCALDW RLYEHFNRTL WAQLRAELGP
301 RRLRGEVERL RARRRELASL CLQDGGALKN HTQIRDPRLR PYQSGKADIL GYNLRPGLDN
361 QTLGVCQRLV MPELQYMARL YALQFPEKPL KNIPFLGALocalizationUniProt · AlphaFold · HPA
Whether an antibody against GAL3ST2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 8.8 nTPM
Expression across tissuesHPA
Tissue
- colon: 8.8 nTPM
- rectum: 3.5 nTPM
- appendix: 0.7 nTPM
- adipose tissue: 0.5 nTPM
- fallopian tube: 0.5 nTPM
- liver: 0.5 nTPM
Single-cell type
- podocytes: 7.2 nCPM
- neuroendocrine cells: 4.5 nCPM
- goblet cells: 4.2 nCPM
- mesothelial cells: 4.2 nCPM
- enteric stem cells: 4 nCPM
- ependymal cells: 4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 4.8 nTPM
- hypothalamus: 4.2 nTPM
- amygdala: 4.1 nTPM
- basal ganglia: 4 nTPM
- pons: 3.9 nTPM
- medulla oblongata: 3.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.89
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.05
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GAL3ST2 as an antibody target. Whether an autoantibody or antibody against GAL3ST2 could matter depends on whether native GAL3ST2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GAL3ST2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GAL3ST2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...